Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRA | AMGN | GILD | CELG | ILMN |
| Company | Atara Biotherap | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 8.00 | 335.15 | 83.26 | 108.01 | 133.64 |
| High | 8.11 | 338.97 | 83.99 | 108.59 | 133.64 |
| Low | 7.60 | 334.27 | 82.75 | 107.27 | 130.36 |
| Last | 7.79 | 337.38 | 83.94 | 108.24 | 131.20 |
| Change | -0.14 | +1.43 | +0.04 | +0.11 | -3.19 |
| % Change | -1.77% | +0.43% | +0.05% | +0.10% | -2.37% |
| Volume | 121,600 | 4,068,200 | 24,925,900 | 191,230,496 | 2,659,500 |
| 20-Day Average Volume | 223,010 | 1,855,500 | 7,644,690 | 16,188,930 | 1,435,735 |
| Previous Close | 7.93 | 335.95 | 83.90 | 108.13 | 134.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.11 | 330.23 | 80.47 | 108.17 | 129.29 |
| 20-Day Raw Stochastic | 28.22% | 91.90% | 89.42% | 63.25% | 68.17% |
| 20-Day Relative Strength | 46.20% | 58.76% | 71.95% | 64.69% | 55.98% |
| Weighted Alpha | -76.12 | +27.84 | +18.32 | +46.30 | +4.95 |
| Today's Opinion | 88% Sell | 100% Buy | 88% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 88% Sell | 96% Buy | 88% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 56% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.86% since 09/13/24 | +1.48% since 09/13/24 | +1.36% since 09/13/24 | -1.97% since 11/13/19 | +1.56% since 09/13/24 |
| Low | 7.60 on 09/20/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 107.27 on 11/20/19 | 127.50 on 09/16/24 |
| High | 9.49 on 09/16/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | +8.50% since 08/20/24 | +2.69% since 08/20/24 | +12.29% since 08/20/24 | +5.14% since 10/18/19 | -0.99% since 08/20/24 |
| Low | 6.65 on 08/27/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 102.40 on 10/21/19 | 120.51 on 09/12/24 |
| High | 10.69 on 09/05/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 136.19 on 09/19/24 |
| 3-Month | |||||
| %Chg | -12.47% since 06/20/24 | +8.87% since 06/20/24 | +22.56% since 06/20/24 | +13.63% since 08/20/19 | +21.20% since 06/20/24 |
| Low | 6.50 on 08/16/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 93.41 on 08/23/19 | 103.52 on 06/28/24 |
| High | 12.98 on 07/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | -56.72% since 03/20/24 | +23.56% since 03/20/24 | +13.46% since 03/20/24 | +14.14% since 05/20/19 | -1.49% since 03/20/24 |
| Low | 6.50 on 08/16/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 100.08 on 05/30/24 |
| High | 20.81 on 04/04/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 38,196 | 180,215,344 | 104,527,072 | 77,035,920 | 21,408,328 |
| Shares Outstanding, K | 4,817 | 536,435 | 1,245,853 | 711,714 | 159,300 |
| Annual Sales | 8,570,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -276,130,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 28,640,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -19,050,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -1,988,000,000 |
| 60-Month Beta | 0.50 | 0.61 | 0.18 | 1.41 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.10 on 08/12/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/06/24 | 10/29/24 | 11/05/24 | 10/31/19 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 17.85 | 10.99 | 142.36 |